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INTRODUCTION 32
Outer membrane vesicles (OMVs) are nano-sized proteoliposomes released from the cell envelope 33 of all Gram negative species of bacteria (Haurat et al, 2015) . OMV release is a highly conserved 34 process, occurring under all growth phases and environmental conditions (Bonnington and Kuehn, 35 2014) . OMVs are able to contain and deliver a range of substrates, from large hydrophobic 36 molecules to DNA, making them a versatile and generalised form of secretion that enhances 37 bacterial fitness in hostile environments (Renelli et al, 2004; Kaparakis et al, 2010; Manning and 38 Kuehn, 2011; MacDonald and Kuehn, 2012) . They also contribute significantly to pathogenesis, 39 via the delivery of virulence factors such as toxins, adhesins and immunomodulatory compounds 40 directly into the host cell (Alaniz et al, 2007; Lindmark et al, 2009; Roy et al, 2011) . In a mouse 41 model, purified OMVs from Escherichia coli were sufficient to cause lethal sepsis in the absence 42 of intact bacterial cells, indicating their potency in enhancing infection and inflammatory processes 43 (Park et al, 2010) . The immunogenicity and ubiquitous production of OMVs has also led to their 44 successful use in vaccine preparations, such as MeNZB against Neisseria meningitidis, 45
representing an application for OMVs in generating immunity against bacterial infections without 46 the risks associated with live cell vaccines (Oster et al, 2007) . Whilst many virulence factors have 47 been identified as OMV cargo, the processes underlying their delivery to host cells during infection 48 are not well characterised. Understanding these mechanisms could help to identify targets for 49 inhibition of OMV-associated toxin delivery and lead to attenuation of bacterial infections, as well 50 as helping to achieve their therapeutic potential in medicine, via vaccines and engineered delivery 51 vehicles (Kim et al, 2008; Gujrati et al, 2014; O'Donoghue and Krachler, 2016) . 52
Host cells are incubated with CCF2-AM, a dye composed of a covalently linked coumarin and 88 fluorescein molecule, resulting in FRET and green fluorescence emission specifically in the 89 eukaryotic cytoplasm where it is processed by esterases, while remaining non-fluorescent in its 90 extracellular form. Cytoplasmic processing also prevents the derivative from exiting the cell, thus 91 trapping the fluorescent derivative in the host cell cytoplasm. When OMVs isolated from the 92 producing bacterial strain enter host cells, their ClyA-Bla fusion cargo is able to cleave CCF2-AM, 93 which abolishes FRET and results in a detectable shift in emission from green (530nm) to blue 94 (460nm) fluorescence ( Figure 1A ). This shift in emission can be monitored in real time to 95 determine the rate of uptake and delivery of OMV cargo to host cells, by comparing the ratio of 96 blue to green fluorescence intensity as an indicator of OMV-host cell interactions. 97 LPS composition determines OMV entry route into host cells |6
ClyA-Bla probes are targeted to EHEC OMVs and retain their enzymatic activity 98
First, we set out to verify whether ClyA-Bla fusion constructs retained the ability of ClyA to 99 partition into vesicles, and were indeed targeted to EHEC OMVs. Following induction of ClyA-100 Bla fusion protein production, OMVs were isolated from EHEC expressing either ClyA-Bla (C-101 terminal fusion) or Bla-ClyA (N-terminal fusion). Western blotting and probing of membranes 102 with Bla-specific antibody revealed the presence of a specific band at 69 kDa, corresponding to 103 intact ClyA-Bla fusion protein in samples from EHEC whole cell lysate, supernatant and OMVs 104 following induction, suggesting that the fusion protein was targeted to and enriched in OMV 105 fractions, as previously reported for non-pathogenic E. coli (Kim et al, 2008) , ( Figure 1B ). Protease 106 protection experiments revealed that the ClyA-Bla probe was oriented with Bla facing the exterior 107 of the OMV, as β-lactamase detection by Western blotting was abolished after prolonged treatment 108 of ClyA-Bla OMVs with papain, while the signal remained stable in OMVs containing Bla-ClyA 109
where Bla faces the vesicle lumen ( Figure 1C ). Enzymatic activity of the probes was assessed by 110 their ability to hydrolyse the β-lactamase substrate nitrocefin. The specific enzyme activity was 111 high for ClyA-Bla OMVs and lower for Bla-ClyA, and both activities were equalized by lysis of 112 vesicles and probe solubilization, suggesting efficient expression of active β-lactamase with the 113 anticipated orientation (inward facing for Bla-ClyA, outward facing for ClyA-Bla) in the isolated 114 OMV fractions ( Figure 1D ). 115
Transmission electron microscopy and nanoparticle tracking analysis confirmed that incorporation 116 of ClyA-Bla probes into OMVs had no observable effect on OMV morphology or size ( Figure 1E , 117 F and S1). Average OMV concentration was 5 x 10 12 particles per ml, with sizes ranging from 10-118 400 nm in diameter, with a mean diameter of 134 nm. The size ranges were in accordance with 119 data obtained previously for OMVs from E. coli (Kim et al, 2008) 
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OMV-targeted enzyme probes report on vesicle uptake and dismantling by host cells 139
Having verified the correct targeting, orientation and enzymatic activity of the ClyA-Bla probes, 140
we set out to use them to dissect the uptake and release of vesicle luminal contents in epithelial 141 cells. Due to their different probe orientation, ClyA-Bla OMVs report on uptake of OMVs into 142 host cells, while Bla-ClyA OMVs report on exposure of luminal cargo, or dismantling of OMVs 143 within host cells. Hela epithelial cells loaded with CCF2-AM and exposed to EHEC ClyA-Bla 144
OMVs at a multiplicity of infection (MOI) of 1000 showed a rapid increase in FRET (and thus 145 OMV uptake) over the course of a 3 hour experiment, while Bla-ClyA caused a slower increase in 146 FRET with a notably later onset compared to ClyA-Bla. OMVs devoid of probe did not cause a 147 significant change in FRET (Figure 2A ). Despite the different rates in FRET change, the total 148 decrease in FRET after 3 hours (i.e., the efficiency of OMV uptake and cargo release, respectively) 149 was similar for ClyA-Bla and Bla-ClyA, indicating both cargo uptake and vesicle dismantling were 150 complete after 3 hours ( Figure 2D ). The rates of FRET change were further analyzed by fitting to 151 a cubic spline function and estimating gradients. While the rate of cargo release is stable throughout 152 the experiment (approx. 0.002 s -1 ), the rate of uptake is initially high (approx. 0.007 s -1 ) but 153 gradually decreases and approaches the rate of cargo release ( Figure 2B 
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E. coli 183
Next, we compared the uptake kinetics of OMVs isolated from EHEC and the non-pathogenic E. 184 coli strain MG1655. Uptake of EHEC OMVs was faster, compared to MG1655 OMVs (Figure  185 3A); the maximal rate was higher ( Figure 3B -C), and a high rate of uptake was sustained for longer 186 than for the non-pathogenic strain ( Figure 3B ). The total change in FRET signal was significantly 187 higher, indicating that the overall efficiency of OMV uptake was higher for EHEC than MG1655 188 ( Figure 3D ). The higher rate and efficiency of uptake of EHEC OMVs compared to non-pathogenic 189
OMVs were independent of OMV size, which was equivalent, or OMV concentration which was 190 normalized for both strains ( Figure S1 ). Uptake rate and efficiency increased with OMV 191 concentration for both EHEC and MG1655, but the maximal rate plateaued at a lower concentration 192 and lower rate for MG1655 ( Figure 3E Complementation with the gne gene from EHEC O157 restored the expression of the O-antigen in 232 EHEC MA6. Despite being isolated from a beef source, MA6 has not been implicated in illness, 233 suggesting a deficiency in its ability to cause infection, despite loss of O-antigen having no effect 234 on growth (Rump et al, 2010) . ClyA-Bla reporter OMVs derived from MA6 entered host cells 235 significantly less efficiently than those derived from EHEC wild type cells with intact O-antigen, 236 and overall uptake was decreased by approximately 43% ( Figure 4D ). The maximum rate of entry 237 of the OMVs from MA6 was not significantly reduced compared with O157 OMVs ( Figure 4C ). 238
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In addition, enzymatic removal of LPS O-antigen from EHEC O157 wild type OMVs was used to 240 compare the effect of LPS composition on OMVs uptake kinetics. Cellulase, which possesses endo-241 1,4-beta-D-glucanase activity, was used to hydrolyze the glycosidic bond between α-L-fucose and 242 ß-D-glucose in the repeating unit of the O157 O-antigen (Wang and Reeves, 1998) and efficiently 243 removed the O-antigen from EHEC LPS ( Figure S2 ). Cellulase-treated EHEC reporter OMVs 244 entered host cells significantly slower than those from wild type EHEC, and total uptake efficiency 245 was decreased by approximately 63% ( Figure 4C ). 246 247 E. coli MG1655 has lost its ability to produce O-antigen due to a disruption in wbbL encoding the 248 rhamnosyltransferase required for O-antigen synthesis (Liu and Reeves, 1994) . In the MG1655 L9 249 strain, wild type wbbL has been restored, allowing expression of the strain's original O16 O-antigen 250 (Browning et al, 2013, Figure S2 ). We carried out FRET assays with Hela cells exposed to Bla reporter OMVs harvested from MG1655 and MG1655 L9 strains, to determine if restoration 252 of its O-antigen would impact OMV uptake kinetics ( Figure 4E -H). HeLa cells incubated with 253 reporter OMVs from MG1655 L9 showed a significantly higher total change in FRET signal 254 compared with cells incubated with OMVs from MG1655 ( Figure 4A , D). There was no significant 255 difference between the maximum rates of uptake, but the rate of uptake decelerated quicker for the 256 MG1655 than the MG1655 L9 strain ( Figure 4B , C), suggesting presence of O16 O-antigen on 257
OMVs causes an increase in efficiency of uptake, but does not affect rate of uptake as much as 258 O157 O-antigen. Taken together, these results suggest that the presence of O-antigen increases the 259 uptake efficiency of OMVs, and depending on the chemical composition of the O-antigen, can 260 enhance the rate of uptake or sustain an elevated uptake rate, compared to LPS lacking O-antigen. 261 
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(G) Maximum rates were determined from data in (F) to visualize speed of uptake for OMVs isolated from MG1655 284 L9 (red) or MG1655 (purple). Data shown are means ± stdev (n=3) and significance was determined using student's 285 t-test. ns-no significant differences.
286
(H) Total FRET changes after 3 hrs were determined from data in (E) and plotted to visualize overall efficiency of 287 uptake for OMVs isolated from MG1655 L9 (red) or MG1655 (purple). Data shown are means ± stdev (n=3) and 2016) have all been proposed as mechanism of vesicle uptake by host cells. These discrepancies 294 may in part be due to differences in OMV composition, as well as methods used to study uptake 295 (O'Donoghue and Krachler, 2016) . We used reporter OMVs to evaluate the relative contribution 296 of cellular trafficking pathways to OMV uptake and determine if these are affected by LPS 297 composition. 298
To evaluate the relative contribution of macropinocytosis, OMV uptake kinetics were studied in 299 untreated cells and compared to Hela cells treated with 20 uM blebbistatin to inhibit 300 macropinocytosis (Jiang et al, 2010) . Inhibition of macropinocytosis slightly enhanced the rate and 301 overall efficiency of uptake, both for EHEC and MG1655 OMVs ( Figure 5 ), suggesting that a small 302 fraction of OMVs usually enters cells by macropinocytosis but that this pathway is not the major 303 route of uptake, and is a slower way of uptake compared to the major route of entry. 304
305
To evaluate whether OMV uptake was dynamin dependent, we compared FRET traces for Hela 306 cells left untreated or treated with 80 uM dynasore to inhibit dynamin-dependent uptake (Nagasawa 307 et al, 2014) prior to incubation with EHEC or MG1655 OMVs. Dynasore treatment almost 308 completely abolished uptake of both EHEC and MG1655 OMVs ( Figure 5 ), suggesting both 309 species use either receptor-mediated endocytosis or caveolin-mediated endocytosis as their major 310 uptake route. 311 
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Chemical composition of LPS determines the preferred route of vesicular uptake by host cells 340
Since our previous experiments had revealed entry of OMVs into host cells was dynamin -341 dependent, we next sought to determine whether the entry of OMVs was dependent on clathrin-342 mediated endocytosis, which utilises protein receptors on the host cell surface, or lipid raft-343 mediated endocytosis, both of which require dynamin (Vercauteren et al, 2010, Chatterjee and 344 Chaudhuri, 2011; Mulcahy et al, 2014) . To inhibit clathrin-mediated endocytosis, protein receptors 345 on host cells were removed by treatment with 5 μg/ml papain prior to incubation with EHEC, 346 MG1655 or MG1655 L9 OMVs. Removal of protein receptors from the host surface led to a 347 marked increase in both rate and efficiency of uptake for EHEC and MG1655 L9 OMVs, but 348 abolished uptake of MG1655 OMVs (Figure 6A-L) . Pre-treatment of host cells with 1 μg/ml 349 chlorpromazine, which disrupts the formation of clathrin-coated pits (Wang, Rothberg and 350 Anderson, 1993) , had a similar effect to papain treatment, and increased rate and efficiency of 351 uptake for EHEC and MG1655 L9, but not for MG1655 OMVs (Figure 6 ). This indicates that 352
OMVs from MG1655, which lack O-antigen, depend on receptor-mediated endocytosis to enter 353 host cells, whereas EHEC and MG166 L9 OMVs, which feature intact O-antigen, are able to utilize 354 receptor-independent pathways as their major route of entry. While a small fraction of EHEC 355 vesicles appears to enter cells via receptor-mediated endocytosis, inhibition of this route actually 356 increases their uptake rate and efficiency. 357
358
OMVs from EHEC preferentially use lipid raft mediated endocytosis to enter host cells 359
Since entry of OMVs containing intact O-antigen seemed to be receptor-independent, we 360 investigated whether these OMVs required lipid rafts to enter host cells. Lipid raft-mediated 361 endocytosis was inhibited using 5 mM methyl-ß-cyclodextrin treatment to sequester cholesterol 362 LPS composition determines OMV entry route into host cells |18 from host cell membranes. Alternatively, cells were treated with 1 μg/ml filipin to disrupt the 363 dynamics of cholesterol-rich microdomains (Nagasawa et al, 2014) prior to incubation with 364 reporter OMVs. Disruption of cholesterol-rich microdomains via both methods led to a marked 365 reduction in rate and efficiency of OMV uptake, and this reduction was most pronounced for EHEC 366
OMVs. Filipin in particular almost completely abolished the uptake of EHEC OMVs ( Figure 6A -367 D). Lipid raft domains can also contain caveolins, which coat cave-like invaginations in the plasma 368 membrane and result in internalization of contents in a process that is also dynamin-dependent 369 (Rewatkar et al, 2015) . Since our previous experiments demonstrated the requirement of dynamin 370 for OMV entry (Figure 5 ), we conclude lipid-raft dependent, caveolin-mediated endocytosis is the 371 major route of entry for EHEC OMVs. 372 LPS composition determines OMV entry route into host cells |20 
Purified LPS competes with EHEC OMVs for caveolin mediated endocytosis 423
Finally, we considered whether purified LPS would competitively inhibit OMV uptake into host 424 cells. Prior to infection with OMVs, HeLa cells were pre-incubated with 1 μg/ml LPS from either 425 smooth or rough strains (i.e, with or without O-antigen). Supplementation with LPS strongly 426 decreased the rate of uptake of EHEC OMVs, but had no significant effect on uptake of OMVs 427 from MG1655 or L9 ( Figure S3 ). LPS is known to associate with the host TLR4 receptor, but 428 inhibition of TLR4 by pre-treatment of cells with C34 (Neal et al, 2013) did not inhibit uptake of 429
OMVs, suggesting that they are not competing for TLR4 ( Figure S4 ). TLR4 activation also requires 430 CD14 binding, a protein localised in cholesterol rich lipid raft domains (Plociennikowska et al, 431 2015) . We demonstrated that entry of EHEC OMVs is strongly dependent on cholesterol-rich 432 regions of the membrane and we suggest that purified LPS, by recruiting TLR4 signaling 433 complexes in cholesterol-rich regions of the membrane, competes with OMVs for binding in these 434 domains, resulting in a reduction in vesicular uptake. 435 436 437 LPS composition determines OMV entry route into host cells |22
DISCUSSION 438
Interactions between bacterial outer membrane vesicles and epithelial cells are now recognized as 439 an important driver of bacterial pathogenesis, and play key roles in toxin delivery, modulation of 440 mucosal immune responses and immune priming. Yet, our ability to study vesicle-host cell 441 interactions and dissect bacterial and host factors determining route of uptake and thus, the fate of 442 vesicular cargo within the host, has been limited by a lack of methods to study vesicle entry and 443 cargo release in real-time and without altering the physicochemical properties of the vesicle. Here 444 we describe a novel assay that fulfils these requirements and allowed us to study the kinetics of 445 OMV uptake with enough temporal resolution to reveal critical differences between rate and uptake 446 efficiency of vesicles derived from pathogenic and non-pathogenic strains. The assay is sensitive 447 enough to register nuanced differences in the kinetics of OMVs decorated with O-antigens of 448 different chemical composition. Current methods for studying the mechanisms of OMV-mediated 449 delivery of bacterial cargo into host cells have produced inconsistent and often contradictory 450 findings, often relying on less quantitative approaches, such as membrane labelling and 451 immunofluorescence, or using changes in cytotoxicity or host cell phenotype as an indicator of 452 OMV cargo delivery. The method presented here provides a consistent platform to further study 453 the pathways involved and measure the kinetics of OMV entry into host cells by utilising a 454 sensitive, adaptable and quantifiable approach that can easily be adapted to a high-throughput 455 format, and potentially to study OMV-host interactions in vivo (Raz et al, 1998) . 456
We selected EHEC as a proof-of-concept species here, since EHEC OMVs have been shown to 457 play a crucial role in toxin stabilization and delivery (Aldick et al, 2008) , and have been considered 458 as a means to vaccinate and protect against hemolytic uremic syndrome, a severe complication of 459 LPS composition determines OMV entry route into host cells |23 EHEC infection (Choi et al, 2014) . However, we expect the genetically encoded ClyA-Bla reporter 460 would similarly be targeted to other Gram-negative species of interest, and this will be subject of 461 further investigation to clarify if the herein identified surface features are equally important 462 determinants in driving uptake of OMVs from other species. 463 Our experiments demonstrated that OMVs from EHEC O157, a successful pathogenic strain of E. 464 coli, enter host cells more rapidly and efficiently than those from the lab strain E. coli MG1655 465 ( Figure 3 ). OMVs are able to transport a wide variety of cargo molecules from the bacterial cell 466 into its external environment, and thus the roles that OMVs have in enhancing bacterial fitness are 467 equally diverse (Kuehn and Kesty, 2005; Haurat et al, 2015) . This data suggests that pathogens 468 such as EHEC may have fine-tuned their cell wall composition in accordance with the role of 469
OMVs for delivery of virulence factors, such as hemolysins and shiga-like toxins, into the host 470 during infection (Horstmann and Kuehn, 2000; Manning and Kuehn, 2011; Bielaszewska et al, 471 2013) . 472
Whilst there are many genes that are likely to contribute to the pathogenesis of EHEC, with 1632 473 proteins present that are absent in MG1655, a significant component of OMVs is LPS, a structure 474 unique to Gram-negative bacteria (Hayashi et al, 2001) . Recent work showed that EHEC OMVs 475 allow efficient delivery of LPS into the host cell cytoplasm, resulting in inflammatory responses, 476 caspase-11 activation and cell death (Kunsmann et al, 2015; Vanaja et al, 2016) . LPS is composed 477 of the well conserved Lipid A, which forms the outer leaflet of the lipid bilayer and is attached to 478 the core oligosaccharide regions, and in 'smooth' strains the core is linked to a highly variable, 479 repetitive polysaccharide region known as O-antigen (Park et al, 2009; Strauss et al, 2009). O-480 antigen is found at the outer-most portion of the LPS and although variable in length, can consist 481 LPS composition determines OMV entry route into host cells |24 of up to 100 repeating units and protrude over 30 nm from the membrane (Strauss et al, 2009 ). The 482 presence of O-antigen can provide several fitness advantages, such as enhancing resistance to 483 complement, phagocytosis and phage infection (Liang-Takasaki et al, 1982; Van der Ley et al, 484 1986 ). Pathogenic strains are often 'smooth', and the O-antigen can increase bacterial virulence, 485 with the length of the O-antigen positively correlated with the ability of the bacterial cell to adhere 486 to host cells and tissues, while loss of O-antigen results in defects in colonisation, biofilm 487 formation, and increased clearance of infection (Sheng et al, 2008; Strauss et al, 2009; Hathroubi 488 et al, 2016) . The importance of O-antigen for adhesion to host epithelial cells has been previously 489 demonstrated in studies using H. pylori, but had not been explored in the context of OMVs 490 (Edwards et al, 2000) . The position of the O-antigen at the outer surface of the OMV means it may 491 be of relevance for establishing initial contact and facilitating adhesion and entry. 492 MG1655 is a 'rough' strain that has undergone a mutation in the wbbL gene of the rfb cluster, 493 causing loss of its native O16 O-antigen (Liu and Reeves, 1994) . When synthesis of the O16 494 antigen was restored to generate MG1655 L9, it was able to colonize the intestine of 495
Caenorhabditis elegans and cause disease, suggesting that the O-antigen is a requirement for 496 pathogenesis (Browning et al, 2013) . In addition, loss of the EHEC O157 antigen results in reduced 497 virulence of the strain in an animal model (Miyashita et al, 2012) . In our experiments, OMVs from 498 EHEC MA6, which lacks the O-antigen, entered host cells significantly less efficiently than OMVs 499 from wild type EHEC. This was also observed when the O-antigen subunits were enzymatically 500 cleaved using a glycoside hydrolase. The presence of O16 antigen for MG1655 L9 OMVs did not 501 significantly affect the maximum rate of uptake, but did significantly increase the overall efficiency 502 of uptake compared to MG1655 OMVs by sustaining a higher uptake rate for longer. These 503 LPS composition determines OMV entry route into host cells |25 differences we observed between O157 and O16 antigens suggest the chemical composition and 504 length of the O-antigen may have a role in fine-tuning entry kinetics and fate of cargo post-uptake. 505
The sugar composition of the O-antigen is highly variable, as is the number of repeating units 506 (Franco, Liu and Reeves, 1998) . The O-antigen of most E. coli strains has 10-18 repeats, whilst 507 EHEC O157 can exceed 80 repeats (Franco, Liu and Reeves, 1998; Kalynych et al, 2011 We used our newly-devised assay to identify the relative contributions of cellular uptake pathways 512 to OMV entry into host cells. Inhibition of clathrin-mediated endocytosis by treatment of cells with 513 papain resulted in a significantly increased rate of uptake for EHEC, but a significant reduction in 514 entry for OMVs from MG1655. For OMVs from MG1655 L9, there was no change in rate but an 515 increased total uptake, suggesting a change in the OMV entry phenotype in the presence of O-516 antigen. This indicates that OMVs without O-antigen rely on protein receptors and clathrin-517 mediated endocytosis in order to gain access to the host cell, whilst OMVs with O-antigen are not 518 inhibited by the loss of this pathway. We propose that the presence of the O-antigen may lead to 519 possible ligands in the inner regions of the LPS being obscured, whereas these potential receptor 520 binding regions are exposed in the absence of O-antigen, and interestingly, loss of the receptor-521 mediated pathway is beneficial to EHEC, and this may be due to a preference for the non-receptor 522 mediated pathways which allow for more efficient cargo delivery from OMVs. 523
When lipid raft mediated endocytosis was inhibited, total uptake of OMVs from all three strains 524 was reduced, but the relative decrease in efficiency was largest for EHEC OMVs, which also 525 LPS composition determines OMV entry route into host cells |26 showed a significant decrease in the rate of uptake ( Figure 6 ). This indicated that in contrast to 526 MG1655, EHEC OMVs preferentially utilize clathrin-independent entry routes. Entry was also 527 dynamin-dependent, suggesting OMVs containing O-antigen are taken up by caveolin-mediated 528 endocytosis. OMVs from EHEC contribute to infection via delivery of diverse virulence factors, 529 and this may be a further adaptation to pathogenesis for EHEC, as although the rate of 530 internalization by caveolae is around 5 times slower than that of clathrin-dependent endocytosis, 531 unlike clathrin-coated pits caveolae do not enter endocytic trafficking routes, and thus are not 532 targeted to lysosomes for processing or degradation (Ritter et al, 1995; Bielaszewska et al, 2013) . 533
Instead, the contents of caveolae rapidly diffuse into the cytoplasm, consistent with our observation 534 of a rapid increase in cytoplasmic dye cleaveage and thus, rapid decrease in FRET almost 535 immediately after vesicle addition to cells. These findings underpin the notion that internalization 536 via caveolin-mediated endocytosis allows more efficient delivery of cargo into host cells (Ritter et 537 al, 1995) . When clathrin-mediated endocytosis is inhibited, it becomes obligatory for OMVs to 538 utilize the more efficient caveolin pathway, which would explain the increased total change in blue 539 fluorescence observed for EHEC OMVs when cells are treated with papain or chlorpromazine. It 540 may be that OMVs from MG1655 lacking O-antigen are less well adapted to using this route, and 541 the presence of the O-antigen on OMVs from MG1655 L9 enhances their ability to use the 542 alternative caveolin-mediated route of entry (Figure 7) . 543
Previous work with H. pylori OMVs had indicated an inhibitory role of extracellular LPS on OMV 544 uptake (Parker et al, 2010) . In our experiments, we found that addition of purified LPS resulted in 545 significant inhibition of uptake of EHEC OMVs, but had no effect on uptake of OMVs from 546 MG1655 or L9. LPS is recognized by the TLR4 receptor on the host cell membrane, but activation 547 of this receptor requires binding of LPS to the CD14 protein which is associated with lipid raft 548 microdomains and caveolae (Shuto et al, 2005; Plociennikowska et al, 2015) . EHEC OMVs were 549 strongly dependent on lipid rafts for their entry, and were most affected by inhibition of this 550 pathway with cholesterol sequestering agents ( Figure 6 ). Inhibition of TLR4 using C34, a small 551 molecule which competitively binds the TLR4-MD2 complex, had no significant effect on uptake 552 of OMVs ( Figure S4 ) (Neal et al, 2013) . In addition, we showed that removal of surface receptors 553 resulted in an increased rate of uptake for EHEC OMVs, suggesting they are not dependent on 554 receptor-mediated endocytosis ( Figure 6 ). We conclude that EHEC OMVs are competing with 555 purified LPS for cholesterol-rich domains of the cell membrane required both for the formation of 556 TLR4 signaling complexes and vesicular uptake, rather than directly competing for the TLR4 557 
